Walter Ling, M.D.

Associate Directors
Richard A. Rawson, Ph.D.
Christine E. Grella, Ph.D.

Senior Advisor
M. Douglas Anglin, Ph.D.
(former Associate Director, 1998-2010)
UCLA ISAP Biennial Report - July 1, 2010 to June 30, 2012 2012 Biennial Report Home Page

UCLA Affiliates

UCLA Center for Addictive Behaviors
UCLA Center for Community Health/CHIPTS
UCLA Hatos Center for Neuropharmacology

UCLA Center for Addictive Behaviors
The mission of the Center for Addictive Behaviors is to discover fundamental mechanisms that link addictive disorders (drug abuse and smoking) and their behaviors with neurochemical phenotype and genotype in healthy individuals and in those who suffer from neuropsychiatric diseases. The Center’s work focuses on two major areas:

  • Research on the biological basis of addictive disorders
  • Development of new probes for noninvasive imaging, including methods to visualize gene expression.

Spread among the West Los Angeles Veteran’s Administration, the UCLA Semel Institute & Resnick Neuropsychiatric Hospital, and the Ahmanson-Lovelace Brain Mapping Center, the Center for Addictive Behaviors uses cutting-edge noninvasive in vivo imaging techniques in its research, placing it at the forefront of drug addiction behavioral research.

In addition to research, the center delivers a variety of courses in drug addiction and abuse, including training in translational research on drug abuse.

For more information, visit Center for Addictive Behaviors.

UCLA Center for Community Health/CHIPTS

The Center for HIV Identification, Prevention, and Treatment Services (CHIPTS), funded by the National Institute of Mental Health, leverages world class science to combat HIV globally, in partnership with communities, families, and individuals impacted by the pandemic. Strategies for integrating, promoting, and diffusing HIV detection, prevention, and care is the primary mission of CHIPTS. Investigators from UCLA, Friends Research Institute, the Los Angeles County Department of Public Health, and research and community partners globally collaborate to achieve CHIPTS’ mission. CHIPTS creates opportunities for scientific leadership, expertise, and infrastructure to create, understand, and evaluate: (1) structural and community level interventions; (2) models of adaptation and adoption of efficacious interventions; (3) strategies to reduce disparities for scientists, nations, communities, and individuals; and (4) research agendas that integrate behavioral, biomedical, and technological intervention strategies. ISAP researchers involved in CHIPTS are Drs. Debra A. Murphy and Cathy Reback.

For more information, visit

UCLA Hatos Center for Neuropharmacology

The Stefan and Shirley Hatos Center for Neuropharmacology focuses on research concerned with addictive drugs, including opioids, nicotine, and psychostimulants. It is also home to the Center for Study of Opioid Receptors and Drugs of Abuse (CSORDA), which is supported by the National Institute on Drug Abuse (NIDA). CSORDA investigates opioid systems at the molecular, cellular, and behavioral levels.

For more information, visit

[ Back to Biennial Report Homepage ]